Who owns Monopar Therapeutics Inc?
- Ticker: MNPR
- CUSIP Number: 61023l108
Tip: Access positions for across all investors
Analyze quarterly positions in Monopar Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Monopar Therapeutics stock
Who bought or sold Monopar Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Two Sigma Securities | 47k | $34k | 100% | Jun 2024 |
|
| Vanguard Group | 45k | $33k | 0% | Jun 2024 |
|
| Virtu Financial | 19k | $14k | -21% | Jun 2024 |
|
| Tower Research Capital | 7.9k | $5.8k | 1% | Jun 2024 |
|
| Goss Wealth Management | 3.0k | $2.2k | 0% | Jun 2024 |
|
Who sold out of Monopar Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 194k | $145k |
| Geode Capital Management | Jun 2024 | 60k | $45k |
| Gerber | Jun 2024 | 28k | $20k |
| Rappaport Reiches Capital Management | Jun 2024 | 11k | $7.8k |